Same Indication

Muromonab-Cd3 vs Rituximab

Muromonab-Cd3 vs Rituximab: Overview

This comparison examines the pharmacological differences between Muromonab-Cd3 and Rituximab.

Mechanism of Action

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Rituximab β€” 22 days.

Chemical Properties

Type: Muromonab-Cd3 β€” Unknown; Rituximab β€” Antibody.